News Agency
Men's Weekly

China NMPA approves RareStone's pitolisant (Wakix) for the treatment of narcolepsy

  • Written by PR Newswire

 -- pitolisant is the first and only treatment drug approved in mainland China for narcolepsy. 

SHANGHAI, July 4, 2023 /PRNewswire/ -- RareStone Group, a rare disease-focused company aiming to establish the first rare disease ecosystem in China, announced that on June 30, the Chinese National Medical Products Administration (NMPA)...

Read more: China NMPA approves RareStone's pitolisant (Wakix) for the treatment of narcolepsy

How Headless CMS Enhances Responsive Design and Layout Flexibility

Image by freepik As digital technology continues to evolve at a breakneck pace, users expect much more from content than ever before, and responsive design is crucial to ensure content not only looks but operates across all screens. No longer are... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion